cefodizime has been researched along with Chronic Kidney Failure in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cree, IA; Henderson, IS; Jones, M; McCafferty, AC; McGregor, E | 1 |
| Hasegawa, H; Horiuchi, A; Horiuchi, H; Imada, A; Itagaki, N; Iwamoto, I; Oono, T; Sakaguchi, M; Takahashi, K; Tsujino, M | 1 |
| Abd el Bary, M; el Guinaidy, MA; Nawishy, S; Sabbour, MS | 1 |
| Dagrosa, E; Ringoir, S; Van Landschoot, N; Vanholder, R | 1 |
1 trial(s) available for cefodizime and Chronic Kidney Failure
| Article | Year |
|---|---|
Pharmacokinetics of cefodizime in normal individuals and in patients with renal failure.
Topics: Adult; Cefotaxime; Drug Administration Schedule; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Metabolic Clearance Rate; Microbial Sensitivity Tests; Middle Aged; Time Factors | 1991 |
3 other study(ies) available for cefodizime and Chronic Kidney Failure
| Article | Year |
|---|---|
The effect of cefodizime on phagocyte function in non-patient volunteers and patients with chronic renal failure. In vitro and ex vivo studies.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Cefotaxime; Cell Polarity; Cephalosporins; Dose-Response Relationship, Drug; Female; Humans; In Vitro Techniques; Kidney Failure, Chronic; Luminescent Measurements; Male; Middle Aged; Phagocytes; Receptors, Cell Surface | 1996 |
[Pharmacokinetics of cefodizime in patients undergoing hemodialysis].
Topics: Cefotaxime; Dialysis Solutions; Humans; Injections, Intravenous; Kidney Failure, Chronic; Renal Dialysis | 1991 |
Cefodizime: a new cephalosporin with apparent immune-stimulating properties in chronic renal failure.
Topics: Cefotaxime; Female; Humans; Injections, Intravenous; Kidney Failure, Chronic; Macrophages; Male; Middle Aged; Phagocytosis | 1988 |